SAN MATEO, Calif.–(BUSINESS WIRE)–Model N, Inc. (MODN), a leader in revenue optimization and compliance, today announced that Jason Blessing, Chief Executive Officer, will present at the JP Morgan 50th Annual Global Technology, Media & Communications Conference. The presentation is scheduled for Wednesday, May 25, 2022 at 5:40a.m. PT (8:40a.m. ET).
A webcast of the live and replay presentation will be accessible from the investor relations page of the Model N website at https://investor.modeln.com/.
About Model N
Model N is the leader in revenue optimization and compliance for pharmaceutical, medtech, and high-tech innovators. Our intelligent platform powers your digital transformation with integrated technology, data, analytics, and expert services that deliver deep insight and control. Our integrated cloud solution is proven to automate pricing, incentive, and contract decisions to scale business profitably and grow revenue. Model N is trusted across more than 120 countries by the world’s leading pharmaceutical, medical technology, semiconductor, and high-tech companies, including Johnson & Johnson, AstraZeneca, Stryker, Seagate Technology, Broadcom, and Microchip Technology. For more information, visit www.modeln.com.
Contacts
Investor Relations Contact:
Carolyn Bass
investorrelations@modeln.com
Media Contact:
Denyse Dabrowski
Bospar Public Relations
denyse@bospar.com
Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…
• Patient 1 of Cohort 1 has now completed the 24-month follow-up timepoint, and at…
LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…
Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…
Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…
Independent analysis examines why 'natural Ozempic alternative' and 'berberine weight loss patch' searches are driving…